← All providers

Mounjaro vs Foundayo

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Mounjaro vs Foundayo: Overview

Choosing between Mounjaro and Foundayo for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Mounjaro focuses on tirzepatide at $1080/month with a rating of 9.2/10. Foundayo offers orforglipron at $149/month with a 9.2/10 rating.

The price difference of $931/month is significant - Foundayo is the more budget-friendly option, while Mounjaro positions itself as a premium service.

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

Visit CoreAge Rx →Read full review

At a glance

Price Difference

$931/mo

Rating Difference

0.0

Winner

Foundayo

Best For

Budget

Mounjaro

View full Mounjaro review →

Rating

9.2/10

Monthly Price

$1080

Medications

tirzepatide

Pros

✓FDA-approved for type 2 diabetes
✓Weekly injection
✓Effective for weight loss (~15-20%)
✓Dual GIP/GLP-1 mechanism
✓Often covered by insurance for diabetes

Cons

✗Primarily approved for diabetes, not weight loss
✗Requires prescription
✗May cause nausea and digestive issues
✗Supply shortages reported

Choose Mounjaro

Foundayo

View full Foundayo review →

Rating

9.2/10

Monthly Price

$149Cheaper

Medications

orforglipron

Pros

✓The first and only FDA-approved GLP-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 April 2026
✓In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4% of body weight) against 2.2 pounds (0.9%) on placebo
✓Counting everyone randomised regardless of whether they finished, the average was still 25 pounds (11.1%) versus 5.3 pounds (2.1%) on placebo - Lilly published both numbers rather than only the flattering one
✓A once-daily tablet, so there is no injection, no needle disposal and no refrigeration to organise
✓Self-pay pricing is published up front at $149 per month for the lowest dose through LillyDirect, with free home delivery
✓Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card
✓Eligible Medicare Part D patients may be able to get it for $50 per month from as early as 1 July 2026 - a rarity in this category
✓Lilly reported reductions in waist circumference, non-HDL cholesterol, triglycerides and systolic blood pressure across all doses
✓It is a small-molecule (non-peptide) GLP-1, which is why it can be manufactured as a pill rather than an injection

Cons

✗Weight loss is meaningfully lower than the best injectables. 12.4% at the top dose sits below tirzepatide territory, so if maximum weight loss is the goal an injection still wins
✗It carries the class boxed warning: it may cause thyroid tumours including thyroid cancer, and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
✗Should not be used alongside another GLP-1 receptor agonist
✗Common side effects include nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, fatigue, heartburn, gas and hair loss
✗Serious risks in the label include pancreatitis, dehydration leading to kidney problems, gallbladder problems, severe allergic reactions and aspiration risk under anaesthesia
✗Safety and effectiveness in children have not been established
✗$149 is the price of the lowest dose only - higher doses cost more, and the $25 and $50 figures depend on insurance eligibility rather than being available to everyone
✗Very new to market, so there is no long-term real-world safety and adherence record yet

Choose Foundayo

Feature-by-feature comparison

Feature	Mounjaro	Foundayo
Monthly Price	$1080	$149
Rating	9.2/10	9.2/10
Medications	tirzepatide	orforglipron
Insurance Accepted	Yes	Yes
Support Hours	Mon-Fri 8AM-8PM ET	Not published
Live Chat	No	No
Free Shipping	No	Yes
Shipping Speed	Varies by pharmacy	Free home delivery via LillyDirect; shipping began 6 April 2026
Mobile App	No	No
Dedicated Coach	Not included	Not included
Follow-up Frequency	As prescribed by physician	As directed by your prescriber
Money-back Guarantee	Savings card available ($25 per month for eligible patients)	None published; this is a prescription medicine, not a subscription service
Cancellation Policy	Prescription-based, consult doctor	Prescription-based - stopping treatment is a decision for you and your prescriber

Which should you choose?

Choose Mounjaro if you:

→Value: fda-approved for type 2 diabetes

Get started with Mounjaro

Choose Foundayo if you:

→Want to save $931/month with a more affordable option
→Value: the first and only fda-approved glp-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 april 2026

Get started with Foundayo

Website previews

Mounjaro

Mounjaro website

Foundayo

Foundayo website

Our recommendation

Foundayo offers better value at $149/month while maintaining strong ratings.

Get started with Foundayo

Related comparisons

Mounjaro vs CoreAge Rx

Mounjaro vs Zepbound

Mounjaro vs Wegovy Pill

Mounjaro vs Wegovy

Mounjaro vs NovoCare Pharmacy

Mounjaro vs Ozempic

Mounjaro vs Form Health

Mounjaro vs Henry Meds

Mounjaro vs Sesame Care

Mounjaro vs FuturHealth

Mounjaro vs Circle Medical

Mounjaro vs Ro

Mounjaro vs Midi Health

Mounjaro vs Noom Med

Mounjaro vs Precision Telemed

Mounjaro vs Hims

Mounjaro vs Calibrate

Mounjaro vs PlushCare

Mounjaro vs LifeMD

Mounjaro vs Ascend Medical

Compare other providers

Compare GLP-1 Brands

First Brand

vs

Second Brand